KRTL BioTech

Latest News on private equity markets

Embraer and Boeing's $4.2 billion deal ruled out pandemic as pretext to cancel

Boeing Co's recently aborted $4.2 billion agreement to buy the commercial jet-making operations of Brazil's Embraer specifically forbade either party from calling it off because of a pandemic or a global economic recession, Reuters has found.



5 years ago

Op-ed: The market comeback seems callous, but investors are betting on a bright post-crisis future

Stocks have risen swiftly as investors look beyond the coronavirus pandemic, but millions of Americans continue to suffer unemployment and sickness.

5 years ago

Exclusive: Wells Fargo shifts energy bankers to focus on bankruptcies

Wells Fargo & Co has revived its special group for bad energy loans in recent weeks as the bank braces for more pain from the sharp downturn in oil prices, people familiar with the matter told Reuters.



5 years ago

Ford wants to restart U.S. car plants shut by coronavirus, if it can convince union

Ford Motor Co on Thursday outlined the safety measures it will institute to restart its most profitable U.S. plants amid the coronavirus pandemic, expanding on similar efforts by General Motors Co and Fiat Chrysler to convince leaders of the United Auto Workers union to send members back to work.



5 years ago

Special Report: FDA's lax rules on coronavirus blood tests open U.S. market to dubious vendors

As the coronavirus pandemic engulfed the United States, Joe Shia, a consultant to Chinese medical companies, said he was bombarded with inquiries from American firms who saw a golden opportunity in selling tests to determine coronavirus immunity.



5 years ago

Wells Fargo will no longer accept applications for home equity lines of credit

Banks have been retreating from loans tied to housing as the coronavirus pandemic impacts home values and the creditworthiness of borrowers.

5 years ago

Amazon's second-quarter forecast weighed down by $4 billion in COVID-19 related costs, shares fall

Amazon.com Inc on Thursday warned that it could post a loss in the second quarter as it tacked on about $4 billion in costs related to the COVID-19 pandemic, sending its shares down 5% in extended trade.



5 years ago

Gilead aims to expand remdesivir output for COVID-19, posts flat 1st-quarter results

Gilead Sciences Inc , maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment.



5 years ago

Apple reports higher sales as China reopens after coronavirus but gives no forecast

Apple Inc reported sales and profits that beat Wall Street expectations Thursday, with Chief Executive Officer Tim Cook saying China sales were "headed in the right direction" as that country reopens from the novel coronavirus.



5 years ago

Wall St. caps best month in decades with broad sell-off

U.S. stocks lost ground on Thursday as grim economic data and mixed earnings prompted investors to take profits at the close of the S&P 500's best month in 33 years, a remarkable run driven by expectations the economy will soon start recovering from crushing restrictions enacted to curb the coronavirus pandemic.



5 years ago

United Airlines posts quarterly loss, shores up $9.6 billion in liquidity

United Airlines Holdings Inc on Thursday posted a first-quarter loss of $1.7 billion, including charges against investments in Latin America that have soured as the coronavirus pandemic jolts travel industries worldwide.



5 years ago

Global equities dip at end of best month since '09

World equity benchmarks dipped on Thursday to close their best month in 11 years as a rebound in oil prices, encouraging early results from a COVID-19 treatment trial and expectations of more government stimulus helped ease the pain of February and March.



5 years ago

Stocks just posted their best month in decades, yet most of Wall Street hates this rally

"History tells us that the odds of another deep decline are very, very high," one strategist said.

5 years ago

Amgen studying Otezla for coronavirus, first-quarter results beat Street estimates

Amgen Inc on Thursday reported better-than-expected first-quarter results on Thursday and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus.



5 years ago

Elon Musk interrupts NASA-SpaceX call during question about his coronavirus views: 'Move on'

SpaceX CEO Elon Musk unexpectedly spoke up during a NASA conference call on Thursday

5 years ago